1. Bayer buying KaNDy for $425M to get menopause market — Putin says Russian COVID-19 vaccine will be ready January 1 — Eisai creating new US HQ in New Jersey — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Arthrex to sell Angel PRP

Discussion in 'Arthrex' started by Anonymous, Aug 13, 2013 at 10:58 AM.

  1. Anonymous

    Anonymous Guest

    How do you guys plan on spinning this one. For years you lied to your customers about how great ACP was, now you will be selling real PRP. Do you just come out and say you were lying?
  2. Anonymous

    Anonymous Guest

    Wow, well that's rather interesting... Do you even know what Angel can do? Who
    We are targeting and what the differences are between them? Maybe you should become slightly educated before you start throwing stones. We are still selling ACP,.. And not sure if you've ever read any of the scientific journals out there... But it works!
  3. It's plasma, thus it is a 'sealant'. Don't drink the koolaide.
  4. At least y'all have a real PRP you don't have to 'spin' the pitch. Granted its a older, challenging system. With your manpower I'm sure you'll make it a moneymaker though for corp.
  5. Anonymous

    Anonymous Guest

    Can anyone elaborate more on the Angel system PRP? I know its one machine that does everything right over standard PRP/serum inj? what are call points and targets for the angel etc? anything else that can be helpful